← Back to Search

Web-based HIV Prevention Toolkit for HIV

N/A

Recruiting

Led By Jason W Mitchell, PhD

Research Sponsored by Florida International University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 3-months, 3-months to 6-months, and baseline to 6-months

Awards & highlights

Study Summary

This trial will research if a digital intervention can help couples stay healthy by using evidence-based strategies and tailored plans.

Who is the study for?

This trial is for cisgender male couples in Lima, Peru who have been in a relationship for over 3 months and are at least 18 years old. They must have had anal sex recently, not experienced partner violence, be willing to test for HIV/STIs, and own a web-connected device.Check my eligibility

What is being tested?

The study tests 'Para ti, para mi, para nosotros (P3),' a digital HIV/STI prevention toolkit designed for male couples. It aims to see if the program increases use of proven prevention strategies compared to those on a waitlist.See study design

What are the potential side effects?

Since this intervention is web-based focusing on education and behavior change rather than medication or medical procedures, traditional physical side effects are not expected.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 3-months, 3-months to 6-months, and baseline to 6-months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 3-months, 3-months to 6-months, and baseline to 6-months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 3-months, 3-months to 6-months, and baseline to 6-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in HIV incidence by comparing results from testing at baseline to 6-months.

Change in STI incidence by comparing results from testing at baseline to 6-months.

Changes in adherence to agreement by comparing responses from baseline to 3-months, 3-months to 6-months, and baseline to 6-months.

+5 more

Trial Design

2Treatment groups

Experimental Treatment

Group I: Waitlist ControlExperimental Treatment1 Intervention

From baseline to 3-months, participants in the waitlist control condition will have access to the P3 web app for post-baseline assessment of 3 months and the resources section. From 3 months to 6 months, participants randomized to the waitlist control arm will then have access to the P3 web app intervention and all of its contents (5 modules, resources, etc.), including post-baseline assessment that will occur at 6 months.

Group II: InterventionExperimental Treatment1 Intervention

From baseline to 6 months, participants randomized to the intervention arm will have access to the P3 web app intervention and all of its contents (5 modules, resources, etc.), including post-baseline assessments that will occur at 3 months and 6 months.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Florida International UniversityLead Sponsor

100 Previous Clinical Trials

17,435 Total Patients Enrolled

University of Southern CaliforniaOTHER

906 Previous Clinical Trials

1,596,168 Total Patients Enrolled

Universidad Peruana Cayetano HerediaOTHER

76 Previous Clinical Trials

61,434 Total Patients Enrolled

Media Library

Para ti, para mi, para nosotros (P3) Clinical Trial Eligibility Overview. Trial Name: NCT05873855 — N/A

Human Immunodeficiency Virus Infection Research Study Groups: Waitlist Control, Intervention

Human Immunodeficiency Virus Infection Clinical Trial 2023: Para ti, para mi, para nosotros (P3) Highlights & Side Effects. Trial Name: NCT05873855 — N/A

Para ti, para mi, para nosotros (P3) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05873855 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the scale of this research undertaking?

"Affirmative. Current records on clinicaltrials.gov declares that this research trial is searching for participants and was initially posted on December 27th 2022 with the most recent edit occurring May 15th 2023. A total of 120 patients are being sought after at a single site."

Answered by AI

Are there currently any opportunities to enroll in this clinical trial?

"Affirmative. According to data hosted on clinicaltrials.gov, this medical trial is presently seeking participants. It was initially posted on December 27th 2022 and the most recent edit took place May 15th 2023. The study requires 120 subjects from one site to partake in it."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Acceptability, Feasibility, and Preliminary Impact of a Web-based, HIV Prevention Toolkit With Cisgender Male Couples in Lima, Peru

2022. "Acceptability, Feasibility, and Preliminary Impact of a Web-based, HIV Prevention Toolkit With Cisgender Male Couples in Lima, Peru". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05873855.

All > Prevention